The cleaning validation processes of companies manufacturing active ingredients continues to be at the forefront of concerns of federal regulators, especially to protect the health and well-being of consumers. Per cGMP and FDA guidelines, cleaning procedures must be repeatable, verifiable and recorded.
In recent times, numerous pharmaceutical companies have been publicly criticized for not properly cleaning their equipment that comes into contact with Active Pharmaceutical Ingredients (APIs) and thus contaminating other products that are manufactured by that machinery. These contaminated products can then be consumed by patients, potentially causing life-threatening complications. More than ever, it’s become essential for these pharmaceutical manufacturing companies to ensure the cleanliness of every piece of apparatus used in manufacturing these products.
Here’s how one multinational pharmaceutical company became GMP compliant whilst increasing production and reducing costs. Find out more by submitting the form below.
Access our previous white papers also available for download.
Hazardous wastes used in testing and research laboratories can cause critical illness, sometimes ending in the loss of life, and can be responsible for detrimental environmental threats when improperly collected or stored.
With our partner Arctiko A/S, a specialist in refrigeration technology, we developed a special material for our customers. In this White Paper you will find the ideal cold storage solution based on the type of sample you are storing, as well as valuable preventive maintenance tips and how to optimize the energy efficiency of your equipment.
Every six months, a new edition of Pharma News will be launched and you will be able to follow the daily operations of IWT, which will share all their experience and know-how in washing technologies for the Life Sciences segment.